These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29102899)

  • 1. HDL functionality in type 1 diabetes.
    Ganjali S; Dallinga-Thie GM; Simental-Mendía LE; Banach M; Pirro M; Sahebkar A
    Atherosclerosis; 2017 Dec; 267():99-109. PubMed ID: 29102899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal high-density lipoprotein composition in women with insulin-dependent diabetes.
    Bagdade JD; Subbaiah PV
    J Lab Clin Med; 1989 Feb; 113(2):235-40. PubMed ID: 2915187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-β1 HDL in type 2 diabetes mellitus.
    Shiu SW; Wong Y; Tan KC
    Atherosclerosis; 2017 Aug; 263():24-28. PubMed ID: 28595104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low HDL-cholesterol--an important risk factor for cardiovascular diseases].
    Reiner Z; Muacević-Katanec D; Katanec D; Tedeschi-Reiner E
    Lijec Vjesn; 2011; 133(3-4):111-6. PubMed ID: 21612108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HDL-cholesterol in an adolescent diabetes population.
    Kuryan RE; Jacobson MS; Frank GR
    J Clin Lipidol; 2014; 8(2):194-8. PubMed ID: 24636179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.
    Femlak M; Gluba-Brzózka A; Ciałkowska-Rysz A; Rysz J
    Lipids Health Dis; 2017 Oct; 16(1):207. PubMed ID: 29084567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction.
    Grant RW; Meigs JB
    Diabetes Care; 2007 Mar; 30(3):479-84. PubMed ID: 17327308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.
    Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M
    Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia in Type 1 Diabetes: AMaskedDanger.
    Vergès B
    Trends Endocrinol Metab; 2020 Jun; 31(6):422-434. PubMed ID: 32217073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report.
    Apro J; Tietge UJ; Dikkers A; Parini P; Angelin B; Rudling M
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):787-91. PubMed ID: 27034474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
    de Vries R; Groen AK; Perton FG; Dallinga-Thie GM; van Wijland MJ; Dikkeschei LD; Wolffenbuttel BH; van Tol A; Dullaart RP
    Atherosclerosis; 2008 Feb; 196(2):733-41. PubMed ID: 17275009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.